U.S. Capital Wealth Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $437K | Buy |
6,668
+1,296
| +24% | +$84.9K | 0.01% | 625 |
|
|
2025
Q1 | $379K | Hold |
5,372
| – | – | 0.01% | 641 |
|
|
2024
Q4 | $353K | Sell |
5,372
-567
| -10% | -$37.3K | 0.01% | 642 |
|
|
2024
Q3 | $419K | Buy |
5,939
+2,342
| +65% | +$165K | 0.01% | 517 |
|
|
2024
Q2 | $239K | Hold |
3,597
| – | – | 0.01% | 614 |
|
|
2024
Q1 | $244K | Sell |
3,597
-675
| -16% | -$45.8K | 0.01% | 606 |
|
|
2023
Q4 | $264K | Buy |
4,272
+675
| +19% | +$41.7K | 0.01% | 579 |
|
|
2023
Q3 | $212K | Hold |
3,597
| – | – | 0.01% | 586 |
|
|
2023
Q2 | $215K | Hold |
3,597
| – | – | 0.01% | 613 |
|
|
2023
Q1 | $210K | Hold |
3,597
| – | – | 0.01% | 601 |
|
|
2022
Q4 | $223K | Hold |
3,597
| – | – | 0.01% | 581 |
|
|
2022
Q3 | $203K | Hold |
3,597
| – | – | 0.01% | 591 |
|
|
2022
Q2 | $230K | Buy |
+3,597
| New | +$230K | 0.01% | 602 |
|